Measles and Mumps Virus Vaccine Live - M-M-Vax
Status: approved but not actively marketed
Organizations involved:
Merck & Co., Inc. – Manuf.; R&D; Tech.; World mark.
Cross ref: See entries for component vaccines – Measles Vaccine (Attenuvax) (#491) and Mumps Vaccine (Mumpsvax) (#504), both from Merck & Co., Inc. See the Measles, Mumps and Rubella Virus Vaccine Live (M-M-R II) entry (#493).
Description: This is a combination vaccine formulated from Measles Vaccine (Attenuvax) and Mumps Vaccine (Mumps-vax), both from Merck & Co., Inc.
Nomenclature: Measles & Mumps Virus Vaccine [BIO]; M-M-Vax [TR]; Measles and Mumps Virus Vaccine Live [FDA]; Measles and Mumps Virus Vaccine, Live [FDA former]
Companies.: This combination vaccine and its components were developed and are manufactured by Merck & Co., Inc. (West Point, PA), FDA CBER est. no. 0002. The vaccine is marketed in the U.S. by Merck & Co., and internationally by Merck & Co. affiliates.
FDA class: Biologic PLA
CBER class: Viral And Rickettsial Vaccines
Approvals: Date = 19730718; first approval, PLA
Date = 19860106; product license revoked under old proper name and granted (reissued) under new (current) proper name
Indications: prevention of disease due to measles and mumps virus infection [unofficial; see insert/labeling].
Market: Average Wholesale Price (AWP) not available (product not in 2007, 2005 or 2004 Red Book), indicating it is not actively marketed in the U.S.
Nearly all children receiving vaccination for mumps and measles now receive the combination measles, mumps, and rubella vaccine (M-M-R II) or newer ProQuad.
Companies involvement:
Full monograph
492 Measles & Mumps Virus Vaccine
Nomenclature:
Measles & Mumps Virus Vaccine [BIO]
M-M-Vax [TR]
Measles and Mumps Virus Vaccine Live [FDA]
Measles and Mumps Virus Vaccine, Live [FDA former]
FDA Class: Biologic PLA
Year of approval (FDA) = 1973
Date of 1st FDA approval = 19730718
(in format YYYYMMDD)
Index Terms:
biopharmaceutical products
bovine materials used<!-- bovinesource -->
chicken source materials
human materials used<!-- humansource -->
live microorganisms (as active agent)
vaccines, combination
vaccines, live
vaccines, viral
cells, human
chicken embryo (egg) culture
Edmonston strain, measles virus
Ender strain, measles virus
Jeryl Lynn strain, mumps virus
mammalian cell culture
measles virus, Edmonston strain
measles virus, Ender strain
mumps virus Jeryl Lynn strain
virus culture
Albumin (Human)
bovine serum, fetal (FBS)
ethanol
gelatin (bovine source)
neomycin
sodium chloride
sodium phosphate
sucrose
approval dates uncertain (FDA reports erroneous, conflicting, or simply has lost the original approval dates) (FDAapproved)
EU200 Currently Approved in EU
UM001 Marketed Product in US
US200 Currently Approved in US
EM001 Marketed Product in EU
Copyright© 2020, Biotechnology Information Institute